The University of Wyoming isn’t particularly known as a party school, but students there apparently do like to drink, and don’t always do it wisely. It has the dubious honor of making the top…
A new Australian study presents strong evidence that people living in areas with a high number of fast-food outlets are more likely to suffer heart attacks than their counterparts elsewhere. The findings were presented…
Akari Therapeutics shares jumped on Wednesday after the firm announced that the FDA has granted Fast Track designation for its stem cell transplant treatment.
Health care spending in America reached a stunning $3.5 trillion in 2017, but that’s just the beginning. According to Centers for Medicare and Medicaid Services, that figure is projected to shoot up to $6…
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
Deciphera Pharma shares nearly doubled on Tuesday after the firm announced top-line results from its late-stage trial treating patients with gastrointestinal stromal tumors.
Alzheimer’s disease and other forms of dementia are a growing worldwide health problem, affecting some 50 million people around the globe, and it’s getting worse. An estimated 10 million people develop the condition annually,…
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Most Americans have never heard of one of the most common forms of skin cancer — one that’s about five times more common than melanoma, and is estimated to kill about twice as many…